- Report
- November 2022
United States
From €3379EUR$3,850USD£2,940GBP
- Report
- November 2022
Italy
From €3072EUR$3,500USD£2,673GBP
- Report
- November 2022
Germany
From €3072EUR$3,500USD£2,673GBP
- Report
- November 2022
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From €12728EUR$14,500USD£11,073GBP
- Report
- November 2022
Japan, United States, ... Japan, United States, Europe, Global
From €21506EUR$24,500USD£18,710GBP
- Report
- November 2022
Europe
From €21506EUR$24,500USD£18,710GBP
- Report
- November 2022
Global
From €30284EUR$34,500USD£26,347GBP
The Infectious Disease Screening market is a subset of the larger Infectious Disease Testing market. It involves the use of tests to detect the presence of infectious agents in a person or population. These tests can be used to diagnose an infection, monitor its progression, or identify individuals who may be at risk of developing an infection. Screening tests are typically used to detect the presence of a wide range of infectious agents, including bacteria, viruses, fungi, and parasites.
Infectious Disease Screening tests are used in a variety of settings, including hospitals, clinics, laboratories, and public health departments. They are also used in research and development, as well as in the food and beverage industry.
The Infectious Disease Screening market is highly competitive, with a number of companies offering a wide range of tests. These include Abbott Laboratories, Becton Dickinson, Cepheid, DiaSorin, Hologic, Luminex, Qiagen, Roche, and Thermo Fisher Scientific. Show Less Read more